Massimino M, Barretta F, Dossena C, Minasi S, et al. Long-term outcome of the Milano-HART strategy for high-risk medulloblastoma, including the impact of molecular subtype. Neuro Oncol 2024 Sep 27:noae189. doi: 10.1093.
PMID: 39331528